ACUTE RESPIRATORY DISTRESS SYNDROME
PREDICTING ARDS IN ADULT ICU PATIENTS WILL TRANSFORM ACUTE RESPIRATORY CARE    

  • Third diagnostic in development 
  • AI analysis of surfactant levels by SIME’s Clinical AI Platform, proven to predict neonatal Respiratory Distress Syndrome (RDS), could also enable early targeted care in patients with ARDS   
  • A clinical study in Denmark is currently underway to determine if rapid ARDS diagnosis could support early interventions in critically ill COVID-19 patients  
  • Product phase: Design & development (clinical validation)*
CLINICAL PUBLICATION: Assessment of pulmonary surfactant in COVID-19 patients

*For investigational use only